Joe Kiani Co-Founder Masimo Corp. The latest legal battle between Irvine-based medical device maker Masimo Corp. and Apple ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...

Wells Fargo analyst Vik Chopra has assigned their bullish stance on MASI stock, giving a Buy rating yesterday. Vik Chopra has given his Buy ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Apple had been hoping to secure an injunction on the sale of Masimo's medical devices in the US. As it turned out, Masimo beat all but three of the patent infringement claims brought by Apple at ...

Surmodics, Inc. SRDX posted a loss per share of 13 cents in the fourth quarter of fiscal 2024 against the year-ago quarter’s ...

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

Unrecognized Contract Revenues: $1.65 billion as of the end of Q3. Masimo Corp (NASDAQ:MASI) reported healthcare revenues of $343 million for the third quarter, representing a 12% growth compared ...

Looking ahead, revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US.

Gilero started as an engineering design firm focused on single-use medical devices and expanded to designing, developing and ...